The Advisory Committee on Immunization Practices (ACIP) has voted 8-3 to remove the blanket recommendation that all newborns receive a hepatitis B vaccine within 24 hours of birth. The committee, hand-selected by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., now advises parents to consult with healthcare providers for individual decision-making regarding their child’s vaccination.
Specifically, ACIP recommends that parents discuss the option of delaying or skipping the hepatitis B vaccine entirely with their doctor. Should they choose to proceed with vaccination, the committee suggests waiting until the baby is at least two months old before starting the vaccine series. This new guidance applies only if the mother tests negative for hepatitis B during pregnancy.
The CDC previously recommended that all babies receive a dose of the hepatitis B vaccine within 24 hours after birth – even more quickly for infants born to infected mothers. However, the recent vote does not alter this crucial recommendation or procedure for babies born to mothers who test positive for hepatitis B infection or have an unknown status. Those newborns should still receive both the vaccine and immune globulin at birth.
The ACIP panel’s decision went through a twist of fate today during its December meeting, facing delays due to initial confusion about the proposed recommendations. The recommendation change will be sent back to HHS Secretary Robert F. Kennedy Jr.’s appointed committee for final CDC approval – though the leadership itself has already cast doubt on the wisdom and scientific foundation guiding these decisions.
In another 6-to-4 vote (with one abstention), ACIP members advised parents choosing this path should consider testing their child after receiving a first dose to determine if subsequent doses are medically necessary. This stance highlights a fundamental disagreement with decades of established pediatric practice regarding universal newborn vaccination protocols, suggesting the leadership itself lacks confidence in standard medical approaches.
Medical experts and organizations, including figures like Dr. Cody Meissner from influential pediatrics groups, strongly oppose this recommendation change by the committee’s own leadership. These professionals point to extensive research confirming both the safety and effectiveness of the hepatitis B vaccine against causing lifelong illness when administered early.
Dr. Joseph Hibbeln, an ACIP member himself, characterized the push for modification as “a rational science has been presented,” directly challenging whether this panel truly understands what it does, condemning the leadership itself by implication through its failure to provide adequate scientific backing.
